250358-67-9

Basic information

• Product Name: 2'-thioethyl-α-D-galactopyranoside
• Synonyms: 2'-thioethyl-α-D-galactopyranoside
• CAS NO: 250358-67-9
• Molecular Weight: 240.277
• Mol File: 250358-67-9.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 2'-thioethyl-α-D-galactopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: 2'-thioethyl-α-D-galactopyranoside(250358-67-9)
• EPA Substance Registry System: 2'-thioethyl-α-D-galactopyranoside(250358-67-9)

Safety Data

• Hazardous Substances Data: 250358-67-9(Hazardous Substances Data)

Upstream product

• 59-23-4 D-Galactose 
• 10257-28-0 D-Galactose 
• 250358-65-7 2-bromoethyl α-D-galactopyranoside 
• 86651-40-3 2'-bromoethyl-2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside 
• 3646-73-9 α-D-galactopyranose 
• 250358-66-8 2 '-thioethyl-α-D-galactopyranoside 

Relevant articles and documents

Convergent synthesis of fluorescein-labelled lysine-based cluster glycosides

The synthesis of fluorescein-labelled lysinyl trees, containing 2, 4 or 8 manno- or galactoside residues, is reported. These lysine-based cluster glycosides have been readily assembled by coupling amino-functionalized, N-chloroacetylated-L-lysinyl trees w

ANTIFOLATE-CARRYING NANOPARTICLES AND THEIR USE IN MEDICINE

The present invention provides a nanoparticle comprising: a core comprising a metal and/or a semiconductor; and a plurality of ligands covalently linked to the core, wherein said ligands comprise: (i) at least one dilution ligand comprising a carbohydrate, glutathione or an ethylene glycol-containing moiety; and (ii) a ligand of the formula D-L1-Z-L2, wherein D comprises an antifolate drug or folic acid, L1 comprises a first linker portion comprising a C2-C12 glycol and/or C2-C12 alkyl chain, L2 comprises a second linker portion comprising a C2-C12 glycol and/or C2-C12 alkyl chain, wherein L1 and L2 may be the same or different, and wherein Z represents a carbonyl-containing group linking L1 and L2, and wherein L2 is coupled to said core, Also provided are pharmaceutical compositions comprising such nanoparticles, medical uses thereof and methods for producing the nanoparticles.

COMBINATION PEPTIDE-NANOPARTICLES AND DELIVERY SYSTEMS INCORPORATING SAME

Nanoparticles having a core and a corona of ligands covalently linked to the core, wherein differing species of peptides are bound to the nanoparticles and incorporated into various dosage forms.